Stock listing
Castle Biosciences, Inc.
Selected listing: 086 · TRADEGATE · EUR · DE
Castle Biosciences, Inc. (Tradegate:086), Health Technology. Latest release Sep 30, 2026: Late-Breaking EADV 2026 Data Support Use of DecisionDx®-Melanoma…
- Ticker
- Tradegate:086
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Medical Specialties
- Exchange
- Tradegate
- Currency
- EUR
Latest news from Castle Biosciences, Inc.
Late-Breaking EADV 2026 Data Support Use of DecisionDx®-Melanoma in SLNB Decision-Making and Risk-Aligned Post Surgical Management
September 30, 2026
New Study Shows That TissueCypher® Changed Management at an Expert Surgery Center in 90% of Patients With Non-Dysplastic Barrett's Esophagus
September 28, 2026
New Study Highlights Clinical Need for Molecular Guidance in Atopic Dermatitis Treatment Selection, Reinforcing the Value of AdvanceAD-Tx™
September 24, 2026
Castle Biosciences to Open New Laboratory Facility in Scottsdale
September 22, 2026
New Decision Modeling Study Demonstrates TissueCypher® Significantly Improves Risk-Aligned Management for Patients with Barrett's Esophagus
September 15, 2026
Events
Research Castle Biosciences, Inc.
Castle Biosciences, Inc. company profile
View the public company page for Castle Biosciences, Inc. on 6ix.
Castle Biosciences, Inc. news
Read company news and market updates connected to Castle Biosciences, Inc..
Castle Biosciences, Inc. investor events
Find investor webinars, events, and replay context for Castle Biosciences, Inc..
Alternate listings
CSTL:NASDAQ
US · USD
Alternate listing for Castle Biosciences, Inc.; the primary context on this page is 086:TRADEGATE.
086:FWB
DE · EUR
Alternate listing for Castle Biosciences, Inc.; the primary context on this page is 086:TRADEGATE.
CSTL:BOATS
US · USD
Alternate listing for Castle Biosciences, Inc.; the primary context on this page is 086:TRADEGATE.